Not Yet Recruiting PHASE1 Interventional 1-arm
NCT02519959
Correlation of FAZA PET Hypoxia Imaging To 3D Histology in Oral Tongue Cancer (FAITH) (FAITH)
Defining a Personalized Hypoxic Radiation Target Through Correlation of Functional F18-FAZA PET Imaging to Pimonidazole-stained 3D Whole-mounted Histological Specimen
Sponsor: Cancer Care Ontario
Conditions
Cancer of the Tongue
Interventions
(F18)-FAZA injection Pimonidazole-HCl
Updated 1 time since 2017 Last updated: Aug 6, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1 clinical study on Cancer of the Tongue, this trial is actively recruiting participants. The trial is conducted by Cancer Care Ontario and has accumulated 1 data snapshot since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE1
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Cancer Care Ontario
- Princess Margaret Hospital, Canada
- Sunnybrook Health Sciences Centre
- Sunnybrook Research Institute
- University of Toronto
- University of Western Ontario, Canada
Data source: Sunnybrook Health Sciences Centre
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.